|
Days of stimulation (N)
|
11 (10–12) [8–15]
|
10 (10–12) [9–15]
|
0.246*
|
|
HMG dose (units)
|
1350 (1200–1500) [626–2475]
|
1800 (1337–3110) [1050–5325]
|
< 0.0001*p
|
|
E2 day 5 (pg/ml)
|
103 (73–182) [14–495]
|
525 (284–703) [82–1328]
|
< 0.0001*p
|
|
E2 day 8 (pg/ml)
|
502 (322–826) [39–1639]
|
1056 (829–1439) [147–4244]
|
< 0.0001*p
|
|
E2 hcg day (pg/ml)
|
1538 (1043–2391) [300–7845]
|
2561 (1600–3238) [482–7793]
|
0.001*
|
|
Progesterone at hCG day (ng/ml)
|
0.8 (0.6–1.1) [0.17–2.5]
|
0.86 (0.6–1.37) [0.2–4.9]
|
0.183*
|
|
Endometrial thickness (mm)
|
9.5 (8.6–10.7) [6.7–13]
|
10 (8.7–10.9) [7.3–15.3]
|
0.25*
|
|
N. oocytes retrieved
|
6 (5–8) [3–17]
|
6 (5–9) [3–17]
|
0.361*
|
|
N. MII oocytes
|
5 (4–7) [2–12]
|
5 (4–7) [2–14]
|
0.593*
|
|
hCG day E2/follicles > 16 mm ratio
|
193 (128–292) [28–569]
|
320 (219–434) [87–974]
|
< 0.0001p
|
|
hCG day E2/total oocyte ratio
|
233 (169–329([53–590]
|
372 (309–660) [116–1025]
|
0.001p
|
|
hCG E2/MII oocytes ratio
|
313 (221–430) [60–1077]
|
473 (309–660) [120–1025]
|
0.001p
|
|
N. embryos
|
3 (2–4) [1–12]
|
3 (2–3) [1–9]
|
0.895*
|
|
N. good quality embryos
|
2 (2–3) [0–8]
|
2 (1.5–3) [0–5]
|
0.864*
|
|
N. transferred embryos
|
2 (2–3) [1–3]
|
2 (2–3) [0–3]
|
0.605*
|
|
N. good quality embryos transferred
|
2 (1–2) [0–3)
|
2 (1–2) [0–3]
|
0.815*
|
|
N. fresh cycles (%)
|
80
|
60
|
0.016#
|
|
Fertilization rate (%)
|
78.9
|
79.9
|
0.941#
|
|
Pregnancy rate in fresh cycles N (%)
|
33/64 (51)
|
10/36 (27.7)
|
0.021§
|
|
Clinical pregnancy rate in fresh cycles N (%)
|
30/64 (46.8)
|
10/36 (27.7)
|
0.061§
|
|
Cumulative pregnancy rates (fresh + cryo) N (%)
|
36/80 (48.7)
|
12/45 (26.6)
|
0.016§p
|
|
Cumulative clinical pregnancy rate N(%)
|
34/80 (42.5)
|
11/45 (24.4)
|
0.044§
|
